Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Irgovel (Indústria Riograndense de Óleos Vegetais) is a leading Brazilian company specializing in the processing of rice bran to produce high-value oils and bioactive compounds. The company is particularly noted for its production of Gamma Oryzanol, a substance used in the pharmaceutical, nutraceutical, and cosmetic industries for its antioxidant and cholesterol-lowering properties. Founded in 1978 and headquartered in Pelotas, Brazil, Irgovel was acquired by the global agribusiness giant Bunge in 2013. It operates as a key industrial unit within Bunge's specialty ingredients portfolio, serving both domestic and international markets. The company's expertise lies in advanced extraction and refining technologies that transform agricultural by-products into functional ingredients for human and animal health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Irgovel.